Plain-English translation of NCT05179954 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand why people with type 1 diabetes have a higher risk of heart disease. This study will compare how your body processes certain fat particles (lipoproteins) if you have type 1 diabetes with how they're processed in people without diabetes. By looking at these differences, scientists hope to find new ways to protect your heart health.
People with type 1 diabetes face a greater risk of heart disease, but doctors don't fully understand why. This research aims to identify specific differences in how the body handles fat particles, which could lead to better treatments and prevention strategies.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll visit the research center for blood draws and possibly other tests to measure how your body processes fat particles. The study compares results between people with type 1 diabetes and healthy volunteers to identify key differences. You'll need to follow specific guidelines about exercise, diet, and medications during the study period.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States
Sponsor
University of Missouri-Columbia
Collaborators
University of Washington
Enrollment target
~30 participants
Started
May 2022
Primary completion
December 2026
Age range
18 Years – 45 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amanda Heider
University of Missouri-Columbia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.